December 19, 2024 Editor’s note: This story contains descriptions of violence that might be too intense for some readers. The dead body rests on Frank Rance’s living room couch. It lays face down, ...

For people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as ...

Ionis won FDA approval for a drug for patients with a deadly genetic disease that impedes the body’s ability to break down ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

Dan Bloomfield, MD, chief medical officer, Anthos, walks through promising findings demonstrating the efficacy of abelacimab, ...